SpaceX shares are drowning in short bets after the stock fell 23% from its IPO peak

SpaceX stock is collapsing under the weight of its own hype, and the market is betting it falls further. Shares have dropped nearly 23% since the company's Nasdaq-100 debut, closing below their IPO price for a second consecutive day after a postponed launch derailed momentum. This isn't ordinary profit-taking; this is a coordinated short attack on a stock most of Wall Street never believed was worth the asking price.

The scale of bearish positioning reveals just how thoroughly investor enthusiasm has evaporated. According to MarketWatch and CNBC reports, approximately 185 million SpaceX shares are sold short, representing roughly 29% of the company's publicly tradable float. That concentration rivals some of the most shorted equities in the market and signals that institutional traders smell weakness, not turnaround potential. When nearly a third of available shares are bets against the company, the structural dynamics tip toward sellers.

Launching delays have crystallized the skepticism. SpaceX shares declined about 4% in premarket trading alone after the most recent Starship test abort, showing how hair-trigger the market has become. Each setback confirms what critics like investor Jeremy Grantham flagged bluntly: the IPO itself was problematic, with Grantham calling it the "craziest IPO in the history of man." The gap between founder-driven vision and financial reality has narrowed fast.

The short thesis now overshadows the long case. SpaceX remains a pioneering aerospace company with genuine technological ambitions, yet the stock has lost the benefit of the doubt. When short interest reaches 29% of float, it means the market has moved from belief to proof-of-concept. The company must execute flawlessly, and immediately, to reverse momentum this steep.